These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 10199460)

  • 21. Advanced aggressive fibromatosis: Effective palliation with chemotherapy.
    Constantinidou A; Jones RL; Scurr M; Al-Muderis O; Judson I
    Acta Oncol; 2011 Apr; 50(3):455-61. PubMed ID: 20799916
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A phase I/II study of vinorelbine, doxorubicin, and methotrexate with leucovorin rescue as first-line treatment for metastatic breast cancer.
    Subramanyan S; Abeloff MD; Bond SE; Davidson NE; Fetting JH; Gordon GB; Kennedy MJ
    Cancer Chemother Pharmacol; 1999; 43(6):497-502. PubMed ID: 10321510
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low-dose chemotherapy of desmoid tumors.
    Weiss AJ; Lackman RD
    Cancer; 1989 Sep; 64(6):1192-4. PubMed ID: 2766217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Timely Oral Option: Single-Agent Vinorelbine in Desmoid Tumors.
    Gennatas S; Chamberlain F; Smrke A; Stewart J; Hayes A; Roden L; Messiou C; Kowa JY; Estival A; Chauhan D; Thway K; Fisher C; van der Graaf WTA; Jones RL; Benson C
    Oncologist; 2020 Dec; 25(12):e2013-e2016. PubMed ID: 32918789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Image Gallery: Complete remission of aggressive desmoid-type fibromatosis after low-dose methotrexate for 2 weeks in a child with psoriasis.
    Simonsen S; Vera Casaño A; Gómez Moyano E; Sanz Trelles A; Bravo Bravo C; Martínez Pilar L
    Br J Dermatol; 2016 Oct; 175(4):e122. PubMed ID: 27650749
    [No Abstract]   [Full Text] [Related]  

  • 26. Vinorelbine, bleomycin and methotrexate as a salvage therapy for patients with head and neck squamous carcinoma in relapse after cisplatin/fluorouracil.
    Iop A; Cartei G; Isaia A
    Ann Oncol; 1998 Feb; 9(2):225-7. PubMed ID: 9553671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Second-line chemotherapy with bleomycin, methotrexate, and vinorelbine (BMV) for patients with squamous cell carcinoma of the head, neck and esophagus (SCC-HN&E) pretreated with a cisplatin-containing regimen: a phase II study.
    Moroni M; Giannetta L; Gelosa G; Secondino S; Chillura G; Colombo E; Siena S
    J Chemother; 2003 Aug; 15(4):394-9. PubMed ID: 12962369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vinorelbine, methotrexate and fluorouracil (VMF) as first-line therapy in metastatic breast cancer: significance of the time between initiation of adjuvant therapy and of therapy for metastatic breast cancer.
    Isik B; Altundag K
    Ann Oncol; 2004 Jan; 15(1):175; author reply 175. PubMed ID: 14679141
    [No Abstract]   [Full Text] [Related]  

  • 29. Control of aggressive fibromatosis by treatment with imatinib mesylate: a step forward?
    Ravaioli A; Nicoletti S; Tamburini E; Papi M
    J Cancer Res Clin Oncol; 2009 Feb; 135(2):325-6. PubMed ID: 18825412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemotherapy in patients with desmoid tumors: a study from the French Sarcoma Group (FSG).
    Garbay D; Le Cesne A; Penel N; Chevreau C; Marec-Berard P; Blay JY; Debled M; Isambert N; Thyss A; Bompas E; Collard O; Salas S; Coindre JM; Bui B; Italiano A
    Ann Oncol; 2012 Jan; 23(1):182-186. PubMed ID: 21444357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of Metronomic Therapy as a Low-Cost, Sustainable, Standard-of-Care Option in Desmoid Fibromatosis: Real-World Data From a Tertiary Care Center in India.
    Bajpai J; Munot P; Kota K; Gupta G; Gala K; Gulia A; Rekhi B; Khanna N; Shetty N; Bhargava P; Srinivas S; Ostwal V; Patil V; Noronha V; Kulkarni S; Laskar S; Prabhash K; Chinnaswamy G; Gupta S; Banavali S
    JCO Glob Oncol; 2024 May; 10():e2300308. PubMed ID: 38723218
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral vinorelbine and cisplatin as induction chemotherapy and concomitant chemo-radiotherapy in stage III non-small cell lung cancer: final results of an international phase II trial.
    Krzakowski M; Provencio M; Utracka-Hutka B; Villa E; Codes M; Kuten A; Henke M; Lopez M; Bell D; Biti G; Merimsky O; Beorchia A; Riggi M; Caux NR; Pouget JC; Dubray B; David P
    J Thorac Oncol; 2008 Sep; 3(9):994-1002. PubMed ID: 18758302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low-dose chemotherapy with methotrexate and vinblastine for patients with desmoid tumors: relationship to CTNNB1 mutation status.
    Nishida Y; Tsukushi S; Urakawa H; Hamada S; Kozawa E; Ikuta K; Ando Y; Ishiguro N
    Int J Clin Oncol; 2015 Dec; 20(6):1211-7. PubMed ID: 25899770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical outcomes of medical treatments for progressive desmoid tumors following active surveillance: a systematic review.
    Tsukamoto S; Takahama T; Mavrogenis AF; Tanaka Y; Tanaka Y; Errani C
    Musculoskelet Surg; 2023 Mar; 107(1):7-18. PubMed ID: 35150408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Desmoid-type fibromatosis in children. Clinical features, treatment response, and long-term follow-up.
    Fortunati D; Kaplan J; López Martí J; Ponzone A; Innocenti S; Fiscina S; Cacciavillano W; Zubizarreta P; Rose A
    Medicina (B Aires); 2020; 80(5):495-504. PubMed ID: 33048794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vinorelbine is an active antiproliferative agent in pretreated advanced breast cancer patients: a phase II study.
    Gasparini G; Caffo O; Barni S; Frontini L; Testolin A; Guglielmi RB; Ambrosini G
    J Clin Oncol; 1994 Oct; 12(10):2094-101. PubMed ID: 7931479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The analysis of treatment of aggressive fibromatosis using oral methotrexate chemotherapy.
    Yoon GW; Kim JD; Chung SH
    Clin Orthop Surg; 2014 Dec; 6(4):439-42. PubMed ID: 25436069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vinorelbine and low-dose cyclophosphamide in the treatment of pediatric sarcomas: pilot study for the upcoming European Rhabdomyosarcoma Protocol.
    Casanova M; Ferrari A; Bisogno G; Merks JH; De Salvo GL; Meazza C; Tettoni K; Provenzi M; Mazzarino I; Carli M
    Cancer; 2004 Oct; 101(7):1664-71. PubMed ID: 15378498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multimodal treatment of children with unresectable or recurrent desmoid tumors: an 11-year longitudinal observational study.
    Lackner H; Urban C; Benesch M; Raith J; Moser A; Sovinz P; Schwinger W; Dornbusch HJ; Triebl-Roth K
    J Pediatr Hematol Oncol; 2004 Aug; 26(8):518-22. PubMed ID: 15284591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vinorelbine-based salvage chemotherapy for therapy-refractory aggressive leukaemias.
    Uckun FM; Morar S; Qazi S
    Br J Haematol; 2006 Nov; 135(4):500-8. PubMed ID: 17061978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.